Table 5

ORs for breast cancer by serum protein levels according to menopausal status

UnitPremenopausalPostmenopausal
OR95% CIOR95% CI
IGF-I
 Crude100 ng/ml1.330.82–2.180.670.38–1.20
 Adjusteda100 ng/ml1.340.82–2.190.740.41–1.34
 Adjustedb100 ng/ml1.700.90–3.200.770.38–1.57
IGFBP-2
 Crude100 ng/ml0.940.79–1.130.760.61–0.96
 Adjustedc100 ng/ml0.970.82–1.140.850.70–1.03
 Adjustedd100 ng/ml0.980.82–1.170.670.50–0.90
IGFBP-3
 Crude1000 ng/ml1.070.99–1.150.960.89–1.03
 Adjustedc1000 ng/ml1.060.99–1.140.950.88–1.02
 Adjustedd1000 ng/ml1.121.02–1.230.950.87–1.03
  • a Adjusted for insulin and glucose (n = 66 pairs premenopausal; n = 55 pairs postmenopausal).

  • b Adjusted for insulin, glucose, and BMI (n = 53 pairs premenopausal; n = 44 pairs postmenopausal).

  • c Adjusted for insulin, glucose, and IGF-I (n = 66 pairs premenopausal; n = 55 pairs postmenopausal).

  • d Adjusted for insulin, glucose, BMI, and IGF-I (n = 53 pairs premenopausal; n = 44 pairs postmenopausal).